生长因子受体单克隆抗体与癌症免疫疗法。 - Suppr

Suppr

超能文献

Growth factor receptor monoclonal antibodies and cancer immunotherapy.

作者信息

Sato G H, Sato J D

出版信息

J Natl Cancer Inst. 1989 Nov 1;81(21):1600-1. doi: 10.1093/jnci/81.21.1600.

DOI:10.1093/jnci/81.21.1600

PMID:2795686

Abstract

摘要

相似文献

Growth factor receptor monoclonal antibodies and cancer immunotherapy.生长因子受体单克隆抗体与癌症免疫疗法。

J Natl Cancer Inst. 1989 Nov 1;81(21):1600-1. doi: 10.1093/jnci/81.21.1600.

Growth factor receptors as targets for antitumor therapy with monoclonal antibodies.生长因子受体作为单克隆抗体抗肿瘤治疗的靶点。

Prog Allergy. 1988;45:147-60. doi: 10.1159/000416378.

EGF mutant receptor vIII as a molecular target in cancer therapy.表皮生长因子（EGF）突变受体vIII作为癌症治疗中的分子靶点。

Endocr Relat Cancer. 2001 Jun;8(2):83-96. doi: 10.1677/erc.0.0080083.

[New developments in immunotherapy for digestive system diseases].[消化系统疾病免疫治疗的新进展]

Nihon Naika Gakkai Zasshi. 2005 Sep 10;94(9):1901-7. doi: 10.2169/naika.94.1901.

[Combined anti-EGFR and anti-HER2 monoclonal antibodies: preclinical efficacy in the treatment of pancreatic cancer].[联合抗表皮生长因子受体（EGFR）和抗人表皮生长因子受体2（HER2）单克隆抗体：胰腺癌治疗的临床前疗效]

Med Sci (Paris). 2007 Oct;23(10):800-3. doi: 10.1051/medsci/20072310800.

Therapeutic application of anti-growth factor receptor antibodies.

Curr Opin Oncol. 1998 Jan;10(1):67-73. doi: 10.1097/00001622-199801000-00011.

Monoclonal antibodies directed at growth factor receptors.针对生长因子受体的单克隆抗体。

Ann Oncol. 2000;11 Suppl 3:187-90. doi: 10.1093/annonc/11.suppl_3.187.

Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function.用于表皮生长因子受体结构与功能研究的单克隆抗体。

Cytotechnology. 1990 May;3(3):279-93. doi: 10.1007/BF00365492.

Antibody-mediated EGF receptor blockade as an anticancer therapy: from the laboratory to the clinic.抗体介导的表皮生长因子受体阻断作为一种抗癌疗法：从实验室到临床

Cancer Immunol Immunother. 2003 May;52(5):342-6. doi: 10.1007/s00262-002-0354-7. Epub 2003 Mar 14.

Iodine-125-labeled anti-epidermal growth factor receptor-425 in the treatment of glioblastoma multiforme. A pilot study.碘-125标记的抗表皮生长因子受体-425治疗多形性胶质母细胞瘤：一项初步研究。

Front Radiat Ther Oncol. 1990;24:151-60; discussion 161-5. doi: 10.1159/000417780.

引用本文的文献

Prevention of tumor metastasis formation by anti-variant CD44.通过抗变体CD44预防肿瘤转移形成

J Exp Med. 1993 Feb 1;177(2):443-55. doi: 10.1084/jem.177.2.443.

Somatostatin analog sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors.生长抑素类似物善宁与转移性内分泌胃肠胰腺肿瘤患者肿瘤生长的抑制

World J Surg. 1993 Jul-Aug;17(4):511-9. doi: 10.1007/BF01655111.

Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalency.在人肺腺癌细胞系Calu-3中，抗体诱导的p185HER2激活需要双价性。

Cancer Immunol Immunother. 1993 Jun;36(6):397-402. doi: 10.1007/BF01742256.

Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site.一种针对表皮生长因子受体结合位点的单克隆抗体的特性分析

Cancer Immunol Immunother. 1991;34(1):37-42. doi: 10.1007/BF01741322.

Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984.单克隆抗体K984靶向头颈部鳞状细胞癌的潜力。

Cancer Immunol Immunother. 1992;34(4):252-8. doi: 10.1007/BF01741793.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验